Zone 1 (EU) including Switzerland and United Kingdom: Belgium, Bulgaria, Denmark (except Faroe Islands and Greenland), Estonia, Finland (excluding land Islands), France (except overseas areas and departments), Germany, Greece (except Mount Athos), United Kingdom (except Channel Islands), Ireland, Italy (except Livigno and Campione d'Italia), Croatia, Latvia, Lithuania, Luxembourg, Malta, Monaco, Netherlands (except non-European territories), Austria, Poland, Portugal, Romania, Sweden, Slovakia, Slovenia, Spain (except Canary Islands, Ceuta + Melilla), Czech Republic, Hungary, Cyprus / Republic (except northern part), including Switzerland
GXP4 knock-out in mice results in embryonic lethality, indicating its unique role and limited number of pathways involved in cellular protection from lipid hydroperoxides
Blood-brain barrier disruption, vascular impairment, and ischemia/reperfusion damage in diabetic stroke
Current research areas include: Soft tissue regeneration Tendon and ligament research Muscle recovery studies Connective tissue remodeling Angiogenesis (new blood vessel formation) Gastrointestinal research Inflammatory pathway investigations Cellular migration and wound healing models Researchers also frequently compare BPC-157 vs TB-500 to evaluate their individual and complementary roles in regenerative peptide research